Evidence map›Paper›PMID 30883359›Full record

ArticleJournal of Alzheimer's disease : JAD2019

Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function.

Adam L Orr, Chaeyoung Kim, David Jimenez-Morales, Billy W Newton, Jeffrey R Johnson, Nevan J Krogan, Danielle L Swaney, Robert W Mahley

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. APOE4 disrupts the central dogma by arresting neuronal proteome dynamics.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. FASEB bioAdvances · 2026
    Article
  11. Predicting Preclinical Cognitive Decline Using Plasma P-tau217 andmedRxiv : the preprint server for health sciences · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Plasma Proteomic Analysis ofmedRxiv : the preprint server for health sciences · 2026
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Adam L OrrGladstone Institute of Neurological Disease, San Francisco, CA, USA.
Chaeyoung KimGladstone Institute of Neurological Disease, San Francisco, CA, USA.
David Jimenez-MoralesGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Billy W NewtonDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
Jeffrey R JohnsonGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Nevan J KroganGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Danielle L SwaneyGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Robert W MahleyGladstone Institute of Neurological Disease, San Francisco, CA, USA.
Gladstone Institutes · USUniversity of California, San Francisco · US

Funding

Apolipoprotein E and Alzheimer's Disease: Mitochondrial Dysfunction and NeurodegenerationR56AG057932 · NIA · J. DAVID GLADSTONE INSTITUTES · PI MAHLEY, ROBERT W. · 2018 to 2018
$782k
NIA NIH HHS R56 AG057932
6 · The paper itself

Abstract

Apolipoprotein (apo) E4, the major genetic risk factor for Alzheimer's disease (AD), alters mitochondrial function and metabolism early in AD pathogenesis. When injured or stressed, neurons increase apoE synthesis. Because of its structural difference from apoE3, apoE4 undergoes neuron-specific proteolysis, generating fragments that enter the cytosol, interact with mitochondria, and cause neurotoxicity. However, apoE4's effect on mitochondrial respiration and metabolism is not understood in detail. Here we used biochemical assays and proteomic profiling to more completely characterize the effects of apoE4 on mitochondrial function and cellular metabolism in Neuro-2a neuronal cells stably expressing apoE4 or apoE3. Under basal conditions, apoE4 impaired respiration and increased glycolysis, but when challenged or stressed, apoE4-expressing neurons had 50% less reserve capacity to generate ATP to meet energy requirements than apoE3-expressing neurons. ApoE4 expression also decreased the NAD+/NADH ratio and increased the levels of reactive oxygen species and mitochondrial calcium. Global proteomic profiling revealed widespread changes in mitochondrial processes in apoE4 cells, including reduced levels of numerous respiratory complex subunits and major disruptions to all detected subunits in complex V (ATP synthase). Also altered in apoE4 cells were levels of proteins related to mitochondrial endoplasmic reticulum-associated membranes, mitochondrial fusion/fission, mitochondrial protein translocation, proteases, and mitochondrial ribosomal proteins. ApoE4-induced bioenergetic deficits led to extensive metabolic rewiring, but despite numerous cellular adaptations, apoE4-expressing neurons remained vulnerable to metabolic stress. Our results provide insights into potential molecular targets of therapies to correct apoE4-associated mitochondrial dysfunction and altered cellular metabolism.

Indexed as

Adenosine TriphosphateAnimalsApolipoprotein E4Cell Line, TumorEnergy MetabolismMiceMitochondriaNADNeuronsProteomeReactive Oxygen SpeciesStress, PhysiologicalTranscriptomeAdenosine TriphosphateApolipoprotein E4NADProteomeReactive Oxygen SpeciesAlzheimer’s diseaseapoE4mitochondrial respirationneurodegenerationneuronal metabolismprotein expression

Identifiers

PMID30883359
PMCPMC6481541
OpenAlexW2922380492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.